These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 18093651

  • 1. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
    Arana-Yi C, Block AW, Sait SN, Ford LA, Barcos M, Baer MR.
    Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
    [Abstract] [Full Text] [Related]

  • 2. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T, Yasuyama M, Kawauchi K.
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [Abstract] [Full Text] [Related]

  • 3. Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Pawarode A, Finlay E, Sait SN, Barcos M, Baer MR.
    Cancer Genet Cytogenet; 2006 Jun; 167(2):155-60. PubMed ID: 16737916
    [Abstract] [Full Text] [Related]

  • 4. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
    Kim YG, Cho SY, Park TS, Oh SH, Yoon HJ.
    Ann Clin Lab Sci; 2011 Jun; 41(1):79-83. PubMed ID: 21325260
    [Abstract] [Full Text] [Related]

  • 5. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T, Nilsson L, Lenhoff S, Rylander L, Astrand-Grundström I, Strömbeck B, Höglund M, Turesson I, Westin J, Mitelman F, Jacobsen SE, Johansson B.
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [Abstract] [Full Text] [Related]

  • 6. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M, Hélias C, Struski S, Perrusson N, Uettwiller F, Mozziconacci MJ, Lafage-Pochitaloff M, Dastugue N, Terré C, Brizard F, Cornillet-Lefebvre P, Mugneret F, Barin C, Herry A, Luquet I, Desangles F, Michaux L, Verellen-Dumoulin C, Perrot C, Van den Akker J, Lespinasse J, Eclache V, Berger R, Groupe Francophone de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 2007 Jul 01; 176(1):1-21. PubMed ID: 17574959
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
    van der Straaten HM, van Biezen A, Brand R, Schattenberg AV, Egeler RM, Barge RM, Cornelissen JJ, Schouten HC, Ossenkoppele GJ, Verdonck LF, Netherlands Stem Cell Transplant Registry "TYPHON".
    Haematologica; 2005 Oct 01; 90(10):1339-45. PubMed ID: 16219570
    [Abstract] [Full Text] [Related]

  • 8. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK, Johansson B, Larsen SO, Pedersen-Bjergaard J.
    Haematologica; 1998 Jun 01; 83(6):483-8. PubMed ID: 9676019
    [Abstract] [Full Text] [Related]

  • 9. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
    Side LE, Curtiss NP, Teel K, Kratz C, Wang PW, Larson RA, Le Beau MM, Shannon KM.
    Genes Chromosomes Cancer; 2004 Mar 01; 39(3):217-23. PubMed ID: 14732923
    [Abstract] [Full Text] [Related]

  • 10. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O, Hofmann WK, Baldus CD, Thiel G, Serbent V, Schümann E, Thiel E, Blau IW.
    Exp Hematol; 2007 Feb 01; 35(2):221-9. PubMed ID: 17258071
    [Abstract] [Full Text] [Related]

  • 11. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersbøll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC.
    Leukemia; 1993 Dec 01; 7(12):1975-86. PubMed ID: 8255096
    [Abstract] [Full Text] [Related]

  • 12. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N, Albin M, Rylander L, Billström R, Ahlgren T, Mikoczy Z, Björk J, Strömberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B.
    Leukemia; 2002 Dec 01; 16(12):2366-78. PubMed ID: 12454741
    [Abstract] [Full Text] [Related]

  • 13. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y, Xu W, Liu Q, Pan J, Qiu H, Wang R, Qiao C, Jiang Y, Zhang S, Fan L, Zhang J, Shen Y, Xue Y, Li J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct 01; 25(5):579-82. PubMed ID: 18841577
    [Abstract] [Full Text] [Related]

  • 14. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 Jul 01; 117(7):963-7. PubMed ID: 15265365
    [Abstract] [Full Text] [Related]

  • 15. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B, Rödjer S, Westin J.
    Ann Hematol; 2008 Jun 01; 87(6):467-74. PubMed ID: 18351338
    [Abstract] [Full Text] [Related]

  • 16. Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer.
    Roman-Unfer S, Bitran JD, Hanauer S, Johnson L, Rita D, Booth C, Chen K.
    Bone Marrow Transplant; 1995 Jul 01; 16(1):163-8. PubMed ID: 7581117
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine: association with therapy-related myelodysplastic syndrome and acute myeloid leukemia.
    Kwong YL.
    J Rheumatol; 2010 Mar 01; 37(3):485-90. PubMed ID: 20080917
    [Abstract] [Full Text] [Related]

  • 18. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R, Yin CC, Miranda RN, Bueso-Ramos CE, Wang XI, Muddasani R, Medeiros LJ, Lu G.
    Cancer Genet; 2013 Mar 01; 206(1-2):42-6. PubMed ID: 23357231
    [Abstract] [Full Text] [Related]

  • 19. Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
    Feldman EJ.
    Best Pract Res Clin Haematol; 2011 Dec 01; 24(4):523-6. PubMed ID: 22127315
    [Abstract] [Full Text] [Related]

  • 20. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.
    Cortes J, O'Brien S, Kantarjian H, Cork A, Stass S, Freireich EJ, Keating M, Pierce S, Estey E.
    Leukemia; 1994 Dec 01; 8(12):2174-8. PubMed ID: 7808007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.